Dactinomycin and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Dactinomycin (dactinomycin), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Vincristine Sulfate, and have Wilms tumor.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Dactinomycin. It is created by eHealthMe based on reports of 2,575 people who have side effects when taking Dactinomycin from the FDA, and is updated regularly.

What is Dactinomycin?

Dactinomycin has active ingredients of dactinomycin. eHealthMe is studying from 2,577 Dactinomycin users. Check the latest studies of Dactinomycin.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,395 drugs and 3,139 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

2,575 people reported to have side effects when taking Dactinomycin.
Among them, 36 people (1.4%) have Haemoglobin decreased.

Could Dactinomycin cause Haemoglobin decreased?

Among these 36 people:

How long have people been on Dactinomycin when they have Haemoglobin decreased? *

What is the gender of people who have Haemoglobin decreased when taking Dactinomycin? *

female: 34.29 %
male: 65.71 %

What is the age of people who have Haemoglobin decreased when taking Dactinomycin? *

What are other drugs people take besides Dactinomycin? *

What are other side effects people have besides Haemoglobin decreased? *

Thrombocytopenia (decrease of platelets in blood): 21 people, 58.33%
Aspartate Aminotransferase Increased: 11 people, 30.56%
Ascites (accumulation of fluid in the abdominal cavity): 11 people, 30.56%
Fever: 9 people, 25.00%
White Blood Cell Count Decreased: 7 people, 19.44%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 16.67%
Febrile Neutropenia (fever with reduced white blood cells): 5 people, 13.89%
Blood Urea Increased: 5 people, 13.89%
Hepatitis B: 5 people, 13.89%
Cytomegalovirus Infection: 5 people, 13.89%

What are the existing conditions these people have? *

Wilms Tumor (cancer of the kidneys that typically occurs in children): 3 people, 8.33%
Neoplasm Malignant (cancer tumour): 2 people, 5.56%
Gestational Trophoblastic Disease (disease of foetus surrounding during pregnancy): 2 people, 5.56%
Benign Hydatidiform Mole (noncancerous (benign) tumour that develops in the uterus): 2 people, 5.56%
Sarcoma Metastatic (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues spreads to other parts): 1 person, 2.78%
Neuroblastoma (a cancer that forms in your nerve tissue): 1 person, 2.78%
Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 2.78%
High Blood Pressure: 1 person, 2.78%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.78%
Fibromatosis (a group of non cancerous soft tissue tumours): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Dactinomycin and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dactinomycin:

Dactinomycin (2,577 reports)

Browse all side effects of Dactinomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Haemoglobin decreased (2,395 drugs)

Browse all the conditions that are associated with Haemoglobin decreased:

Haemoglobin decreased (3,139 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dactinomycin (the active ingredients of Dactinomycin) and Dactinomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.